{"transactions":[{"id":1318388,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84593,"kind":"person","name":"Schroeder Maria","position":1,"cik":"0001906106","reported_name":"Schroeder Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2025-01-03T02:23:31.000Z","date":"2024-12-30","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the options vested on the date of grant in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2024 Long-Term Incentive Plan."}],"balance_after":20000,"derivative":{"exercise_price":0.5995,"expiration_date":"2034-12-30","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001493152-25-000138","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326706/000149315225000138/ownership.xml","form_type":"4"}},{"id":1622126,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84593,"kind":"person","name":"Schroeder Maria","position":1,"cik":"0001906106","reported_name":"Schroeder Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-24T00:19:35.000Z","date":"2024-01-23","kind":"grant","planned":false,"acquired":true,"shares":16667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the option vested on January 23, 2024, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":16667,"derivative":{"exercise_price":0.9,"expiration_date":"2024-01-23","underlying":"Common Stock","underlying_shares":16667},"source":{"system":"sec-edgar","filing":"0001493152-24-007745","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326706/000149315224007745/ownership.xml","form_type":"4"}},{"id":1723560,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84593,"kind":"person","name":"Schroeder Maria","position":1,"cik":"0001906106","reported_name":"Schroeder Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-05T01:45:09.000Z","date":"2023-11-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the option vested on September 13, 2022 (the \"2022 Date of Grant\"), with an additional 25% to vest on the three-month anniversary of the 2022 Date of Grant, a further 25% to vest on the six-month anniversary of the 2022 Date of Grant, and the final 25% to vest on the nine-month anniversary of the 2022 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":0,"derivative":{"exercise_price":8.94,"expiration_date":"2032-09-13","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001493152-23-043632","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326706/000149315223043632/ownership.xml","form_type":"4"}},{"id":1723559,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84593,"kind":"person","name":"Schroeder Maria","position":1,"cik":"0001906106","reported_name":"Schroeder Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-05T01:45:09.000Z","date":"2023-11-15","kind":"grant","planned":false,"acquired":true,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the option vested on November 15, 2023, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":3333,"derivative":{"exercise_price":1.24,"expiration_date":"2033-11-15","underlying":"Common Stock","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0001493152-23-043632","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326706/000149315223043632/ownership.xml","form_type":"4"}}]}